These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23907438)

  • 1. Design and synthesis of a reagent for solid-phase incorporation of the phosphothreonine mimetic (2S,3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) into peptides in a bio-reversible phosphonyl-bis-pivaloyloxymethyl (POM) prodrug form.
    Qian WJ; Burke TR
    Amino Acids; 2013 Nov; 45(5):1143-8. PubMed ID: 23907438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of Fmoc-Thr[PO(OH)(OPOM)] for the preparation of peptide prodrugs containing phosphothreonine in fully protected form.
    Qian WJ; Lai CC; Kelley JA; Burke TR
    Chem Biodivers; 2014 May; 11(5):784-91. PubMed ID: 24827688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of orthogonally protected (
    Liu F; Park JE; Lee KS; Burke TR
    Tetrahedron; 2009 Nov; 65(47):9673-9679. PubMed ID: 24954959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-based inhibitors of Plk1 polo-box domain containing mono-anionic phosphothreonine esters and their pivaloyloxymethyl prodrugs.
    Qian WJ; Park JE; Lim D; Park SY; Lee KW; Yaffe MB; Lee KS; Burke TR
    Chem Biol; 2013 Oct; 20(10):1255-64. PubMed ID: 24120332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatase-Stable Phosphoamino Acid Mimetics That Enhance Binding Affinities with the Polo-Box Domain of Polo-like Kinase 1.
    Hymel D; Burke TR
    ChemMedChem; 2017 Feb; 12(3):202-206. PubMed ID: 27992122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective synthesis of CF(2)-substituted phosphothreonine mimetics and their incorporation into peptides using newly developed deprotection procedures.
    Otaka A; Mitsuyama E; Kinoshita T; Tamamura H; Fujii N
    J Org Chem; 2000 Aug; 65(16):4888-99. PubMed ID: 10956468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioselective synthesis of N(alpha)-Fmoc protected (2S,3R)-3-phenylpipecolic acid. A constrained phenylalanine analogue suitably protected for solid-phase peptide synthesis.
    Liu DG; Gao Y; Wang X; Kelley JA; Burke TR
    J Org Chem; 2002 Mar; 67(5):1448-52. PubMed ID: 11871872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quaternary β
    Yu JS; Noda H; Shibasaki M
    Angew Chem Int Ed Engl; 2018 Jan; 57(3):818-822. PubMed ID: 29168280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fmoc/solid-phase synthesis of Tyr(P)-containing peptides through t-butyl phosphate protection.
    Perich JW; Reynolds EC
    Int J Pept Protein Res; 1991 Jun; 37(6):572-5. PubMed ID: 1717394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient synthesis of phosphorylated prodrugs with bis(POM)-phosphoryl chloride.
    Hwang Y; Cole PA
    Org Lett; 2004 May; 6(10):1555-6. PubMed ID: 15128234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Bottom-Up Approach To Preserve Thioamide Residue Stereochemistry during Fmoc Solid-Phase Peptide Synthesis.
    Camacho LA; Lampkin BJ; VanVeller B
    Org Lett; 2019 Sep; 21(17):7015-7018. PubMed ID: 31403302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 5'-methylene-phosphonate furanonucleoside prodrugs: application to D-2'-deoxy-2'-α-fluoro-2'-β-C-methyl nucleosides.
    Pradere U; Amblard F; Coats SJ; Schinazi RF
    Org Lett; 2012 Sep; 14(17):4426-9. PubMed ID: 22917194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of orthogonally protected hypusine for solid-phase peptide synthesis.
    Song A; Tom J; Yu Z; Pham V; Tan D; Zhang D; Fang G; Yu T; Deshayes K
    J Org Chem; 2015 Apr; 80(7):3677-81. PubMed ID: 25769022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-phase synthesis of D-fructose-derived Heyns peptides utilizing N
    Schmutzler S; Knappe D; Marx A; Hoffmann R
    Amino Acids; 2021 Jun; 53(6):881-891. PubMed ID: 33934222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of Fmoc-Dab(Mtt)-OH during solid-phase peptide synthesis: a word of caution.
    Lam PL; Wu Y; Wong KL
    Org Biomol Chem; 2022 Mar; 20(13):2601-2604. PubMed ID: 35258068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convergent Synthesis of Thioether Containing Peptides.
    Mourtas S; Katakalou C; Gatos D; Barlos K
    Molecules; 2020 Jan; 25(1):. PubMed ID: 31948062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Atom-Economic Inverse Solid-Phase Peptide Synthesis Using Bn or BcM Esters of Amino Acids.
    Li J; Zhu Y; Liu B; Tang F; Zheng X; Huang W
    Org Lett; 2021 Oct; 23(19):7571-7574. PubMed ID: 34533312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphothreonine as a catalytic residue in peptide-mediated asymmetric transfer hydrogenations of 8-aminoquinolines.
    Shugrue CR; Miller SJ
    Angew Chem Int Ed Engl; 2015 Sep; 54(38):11173-6. PubMed ID: 26246129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-N intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence-containing bioactive peptides.
    Sohma Y; Hayashi Y; Skwarczynski M; Hamada Y; Sasaki M; Kimura T; Kiso Y
    Biopolymers; 2004; 76(4):344-56. PubMed ID: 15386265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A convenient preparation of N (ε)-methyl-L-lysine derivatives and its application to the synthesis of histone tail peptides.
    Chi H; Islam MS; Nsiama TK; Kato T; Nishino N
    Amino Acids; 2014 May; 46(5):1305-11. PubMed ID: 24562477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.